. Volume 65 The index to Volume 65 is composed of three parts: a subject following: Alternative Therapies, Current Literature, Editorials, index, an author index, and an advertising index. Frontline Pharmacist, Informatics Interchange, Letters, Manage- The primary index terms for each article are listed routinely in ment Consultation, New Practitioners Forum, News, Practice AJHP as “index terms” after abstracts. Items that were published Spotlight, Pharmacy Abroad, Q&A, and Success Skills. The subject in the ASHP Reports section, including official ASHP Statements index also contains, under the heading “Correction Notices,” the and Guidelines, are indexed under “American Society of Health- title and issue of publication of items for which corrections were System Pharmacists,” as well as being covered by IPA in many printed, as well as the page numbers on which the corrections cases. The subject index also notes all regular AJHP columns and, appear. under the respective column headings, the titles of items in the Issue Pages Issue Pages January | 1-88 July 1 Supplement S1-S18 January 15 89-182 July 15 1293-1388 January 15 Supplement S1-S30 July 15 Supplement $1-S25 February | 183-270 August | 1389-1484 February | Web only el—e2 August 1 Supplement $1-S32 February 15 271-372 August 15 1485-1580 February 15 Web extended e3-e9 August 15 Web only e36-e5 | March 1 373-474 September | 1581-1676 March 15 475-580 September 1 Web only e52 April 1 581-676 September 15 1677-1780 April 15 677-782 October 1 1781-1868 April 15 Web only e10-e18 October 15 1869-1980 May | 783-878 November | 1981-2072 May | Supplement S1-S17 November | Web extended e53-e7 1 May 15 879-986 November 15 2073-2176 May 15 Supplement S1-S24 November 15 Web only e72-e79 June | 987-1098 December | 2177-2300 June | Supplement S1-S24 December | Supplement $1-S25 June 15 1099-1196 December 15 2301-2428 July 1 1197-1292 December 15 Supplement S1-S17 July 1 Web extended e19-e35 December 15 Web only e80 July 1 Web only e34—e35 Administrators Alcohols, isopropyl Subject Index hospital pharmacy, 1700, 2014 poisoning, 2203 Admixtures, see Additives Alcohols, methyl Adrenergic agents, see Sympathomimetic poisoning, 2200 A agents Aliskiren Adverse reactions, see Drugs, adverse reactions hypertension, 1321, 1323 Absorption Advertising Index, 88, 182, 270, 372, 474, 580, Allergies drugs, 254 676, 782, 878, 986, 1098, 1196, 1292, 1388, drugs, 1177 Accreditation 1484, 1580, 1676, 1780, 1868, 1980, 2072, Alteplase hospitals, 1590, 2084 2176, 2300, 2428 peripheral vascular diseases, 1435 Acetylcysteine Age Alvimopan respiratory distress syndrome 529 patients, 1242, Jun 1 suppl S8 therapy, 1204 stability, 558 Aggregation Alzheimer disease Acidosis mercaptopurine, 441 rivastigmine, 1051 topiramate, 1430 AIDS, see Acquired immunodeficiency Ambulatory care Actonel, see Risedronate sodium syndrome darbepoetin alfa, 385 Acute coronary syndrome Air pharmaceutical services, 145, 229, 631, 844, anticoagulants, Aug 1 suppl $22 control, quality, 1443 1744, 1841 platelet aggregation inhibitors, 1017, Jul 1 AJHP, see American Journal of Health-System warfarin, 1498 suppl $5, Aug | suppl $22 Pharmacy American Academy of Pediatrics Additives AJHP Continuing Education, Jan 15 suppl S27, protocols, Dec 1 suppl $7, Dec 1 suppl S13 injections, 14 May | suppl S16, May 15 suppl $23, Jun 1 American Diabetes Association Adhesion suppl $22, Jul 1 suppl S16, Jul 15 suppl $23, protocols, 145 patches transdermal, 1337 Aug | supp! $29, Dec 1 suppl $23, Dec 15 American Journal of Health-System Pharmacy Adhesives suppl S16 acknowledgment of reviewers, November 1, patches transdermal, 1337 Albuterol 2007, to October 31, 2008, 2387 Administration respiratory distress syndrome, 29 administration, 1511 American Journal of Health-System Pharmacy, Alcoholism American Society of Health-System 1511 poisoning, 2203 Pharmacists American Society of Health-System varenicline, 1624 ASHP policy recommendations—invitation Pharmacists, e36, e39, e41 Alcohols, ethyl to comment, el4 education, pharmaceutical, 17 97 abuse, 611 awards, 2055, e49 hospital pharmacy, 340, 1700, 2014, 2144 antidotes, 2200 Board of Directors; actions, January 17-18, pharmacy, 20 poisoning, 2203 2008, meeting, e10; actions, April 16-18, policies and procedures, 1996, e44 withdrawal, 1039, 2205 2008, meeting, e34; actions, June 23 and Am J Health-Syst Pharm—Vol 65 Dec 15, 2008 2399 ANNUAL INDEX 7 26, 2007, meeting, e18; actions, June 7 and irbesartan, 420 rational therapy, 1396 10, 2008, meeting, e52; actions, September lisinopril, 420 resistance, 1154, 1396, May 1 suppl S2, May 1 25-26, 2008, meeting, e80 Angiotensin antagonists suppl S4 Board of Directors Award of Honor, e2 irbesartan, 420 rifaximin, 705, 818 council recommendations, e14 Angiotensin-converting-enzyme inhibitors Staphylococcal infections, 219 Distinguished Leadership in Health-System diabetes mellitus, 935 therapy, 1333 Pharmacy Practice Award, el enalapril, 420 toxicity, 705 education, pharmaceutical, 1508 lisinopril, 420 Antiinflammatory agents Excellence Award, e49 Antiarrhythmic drugs, see Cardiac drugs ibuprofen, 37 Executive Vice President and Chief Executive Antibiotics Antilipemic agents Officer; report of, e39 dalbavancin, 599 ezetimibe, combination, simvastatin, 594 guidelines, 172, 260, 462, 728, 1272, 1368, doripenem, 1261 fenofibrate, 138 1803, 2380, 2384 vancomycin, 49, 705, 1248, 1740 lovastatin, 101 Harvey A. K. Whitney Lecture Award; 1513 Antibodies Antineoplastic agents Honorary Membership, e50 monoclonal, 18, Jun 1 suppl $3, Jun 1 suppl arsenic trioxide, 941 hospital pharmacy, 827, 2244 S8 Jun 1 suppl S15, 1413, 1609, 1805, Dec bendamustine hydrochloride, 793 House of Delegates; professional policies 1 suppl S13 bortezomib, 1221 adopted [approved] by [2008] the 60th Anticoagulants breast neoplasms, May 15 suppl $4, May 15 annual session, e44; 2008 session, members acute coronary syndrome, Aug | suppl $22 suppl S16 of, e48 argatroban, 334 capecitabine, 2017, 2032 meetings, 358 education, pharmaceutical, 1508 clinical studies, 795 Midyear Clinical Meeting; program, 1894 enoxaparin, 37 colorectal neoplasms, Jun | suppl S8, Jun 1 organizations, e36, e39, e41 fondaparinux, 334 suppl S15 policies and procedures, e44 heparin, 280, 334, 1144, 1643, Aug 1 suppl $13 compounding, 14 Practitioner Recognition Program—2008 heparin sodium, 1735 cyclophosphamide, 1552 Fellows, 1284, e23 lepirudin, 334 docetaxel, 1552 President and Chair of the Board; report of, medical histories, 60 doxorubicin, 1552 e36 protocols, 1396, 1490 epothilone B, May 15 suppl $10 President-elect of the Board; report of, 1571 venous thromboembolism, Aug | supp! $5 epothilones, May 15 suppl $10 Proceedings of the 2007 ASHP Conference warfarin, 800, 947, 964, 1144, 1498, Aug 1 fluorouracil, combination, lidocaine for Leaders in Health-System Pharmacy, suppl $13 hydrochloride, 1830 1270, e19 warfarin sodium, 2113 ifosfamide, 2229 protocols, 343 Anticonvulsants iobenguane sulfate, 142 quality assurance, 1512 carbamazepine, 1039 ixabepilone, 2017, May 15 suppl $10 Summer Meeting; program, 734 gabapentin, 1039 lapatinib, 1703 technicians, 1798 interactions, 1720 levoleucovorin, 686 Treasurer; report of, e41 phenytoin, 1048 lymphoma, 1471 Aminoglycosides topiramate, 1430 melanoma, Dec 15 suppl $3, Dec 15 suppl S9 gentamicin, 49, 624 Antidepressants mercaptopurine, 441 streptomycin, 2027 bupropion, 1530, 1627 methotrexate, 686, 2117 Amiodarone depression, 700, 1108 nanoparticles, 1988 interactions, 947, 2232 insomnia, 927 paclitaxel, 1333 Amlodipine toxicity, 1029 raloxifene, 2221 concomitant therapy, 1051 Antidiabetic agents sorafenib, 123 Amphetamines diabetes mellitus, 488 sunitinib, 123 abuse, 611 metformin, 521 tamoxifen, 23, 2221 Analgesics and antipyretics pioglitazone, 1846 Antioxidants medical histories, 60 rosiglitazone, 1846 ascorbic acid, 441 nitrous oxide, 2205 sitagliptin, 521 sodium thiosulfate, 1419 pain, 1560, 1588 thiazolidinediones, 521 Antiparkinson agents Anemia Antidiuretic agents Parkinson disease, 414 epoetin alfa, 540 desmopressin, 941 Antiphospholipid syndrome epoetin beta, combination, polyethylene Antidotes warfarin, 964 glycol monomethyl ether, 10 alcohols, ethyl, 2200 Antiprotozoals hematopoietic agents, 1218, 1458, 1711 fomepizole, 2200 nitazoxanide, 705 hydroxyurea, 592 Antiemetics Antipsychotic agents iron sucrose, 150 aprepitant, 2229 aripiprazole, 2007 paclitaxel, 1333 droperidol, 201 chlorpromazine, 2092 Anesthetics nausea, 414 clozapine, 1825 drug administration, 655 palonosetron hydrochloride, 1735 haloperidol, 2232 propofol, 2090 Antifungals olanzapine, 1180 Anesthetics, local caspofungin acetate, 454 paliperidone, 401, 403, 2122 lidocaine, 723 fluconazole, 619, 2237 psychotic disorders, 414 lidocaine hydrochloride, 1735 itraconazole, 2237 quetiapine, 611 lidocaine hydrochloride, combination, posaconazole, 2237 risperidone, 401 fluorouracil, 1830 Antihemophilic factor schizophrenia, 42 pain, 723 hemophilia A, 592 toxicity, 1029 prilocaine, 723 Antiinfective agents Antiretroviral agents Angioedema heart surgery, 2008 HIV infections, 55, 686, 1796 bupropion, 1627 incompatibilities, 1834 indinavir, 422 Cl inhibitor, 2080 metronidazole, 705 ritonavir, 422 enalapril, 420 protocols, 203, 2095 Antisickling agents hydroxyurea, 592 2400 Am J Health-Syst Pharm—Vol 65 Dec 15, 2008 ANNUAL INDEX EB Antituberculars interactions, 1180 Buffers isoniazid, 2027 therapy, 1039 sodium phosphate dibasic, 73 pyrazinamide, 2027 Beriplast sodium phosphate monobasic monohydrate, rifampin, 2027 pneumothorax, 322 44] Antivirals Bevacizumab Buffington, D. hepatitis B, 2184 colorectal neoplasms, Jun | suppl $3, Jun 1 awards, e49 myocarditis, 132 suppl S8, Jun 1 suppl S15 Bupropion Anxiolytics, sedatives and hypnotics concomitant therapy, 2032 toxicity, 1530, 1627 diazepam, 2122 Bid contracting, see Purchasing Buserelin acetate insomnia, 927, 1004 Bile acid resins toxicity, 1148 lorazepam, 49, 2007 clostridium infections, 705 Bystolic see Nebivolol hydrochloride Apparatus, see Equipment Billing Aprepitant anesthetics, 655 C interactions, 2229 pharmacy, 701, Jan 15 suppl S4 Aranesp, see Darbepoetin alfa Bioavailability, see Drugs, availability Argatroban Biologicals Cl inhibitor thrombocytopenia, 334 approvals, 190 angioedema, 2080 Aripiprazole biotechnology, Jul 15 suppl S16 Calcimimetics incompatibilities, 2007 equivalency, therapeutic, Jul 15 suppl $2, Jul cinacalcet, 1419 Arsenic trioxide 15 suppl S9 Calciphylaxis toxicity, 941 Biotechnology therapy, 1419 Arsidia chinensis biologicals, Jul 15 suppl S16 Calcium antagonists myocarditis, 132 Bisphosphonates clevidipine butyrate, 1686 Arthritis calciphylaxis, 1419 scleroderma, 315 tocilizumab, 1413 osteoporosis, 297 Calcium salts Ascorbic acid risedronate sodium, 2133 incompatibilities, 73 effects, 441 Bivalirudin California ASHP, see American Society of Health-System acute coronary syndrome, Aug | suppl S22 disasters, 2006 Pharmacists Blood Calories ASHP?’s CareerPharm, 83, 176, 264, 361, 468, transfusions, 540, 941 propofol, 2090 575, 672, 775, 875, 982, 1083, 1192, 1288, Blood levels Canada 1385, 1479, 1577, 1672, 1775, 1864, 1973, anticonvulsants, 1720 pharmacists, 2126 2066, 2169, 2285, 2391 creatinine, 138 Cancer, see Antineoplastic agents Aspirin gentamicin, 624 Cancer drugs, see Antineoplastic agents acute coronary syndrome, Jul 1 suppl S5 indinavir, 422 Cangrelor cardiovascular diseases, Jul 1 suppl S1, Jul 1 lapatinib, 1703 cardiovascular diseases, Jul 1 suppl S11 suppl S11 omeprazole, 422 Capecitabine therapy, 1134 ritonavir, 422 toxicity, 2032 Asthma tacrolimus, 226 Capital punishment therapy, 1533 vancomycin, 1248, 1740 ethics, 2204 Astragalas membranaceus Blood pressure Carbamazepine myocarditis, 132 tests, 209 therapy, 1039 Atrial fibrillation Blood substitutes Carboplatin paliperidone, 2122 therapy, 1110 concomitant therapy, 2229 Atrioventricular block Book Correction Notice, 596, 1794, 2087 Carcinoma rivastigmine, 1051 Book reviews, 1286 sorafenib, 123 Atropine sulfate Introduction to Public Health in Pharmacy, sunitinib, 123 incompatibilities, 1735 1286 Cardiac drugs Automation The Cigarette Century: The Rise, Fall, and amiodarone, 947, 2232 documentation, 655 Deadly Persistence of the Product That conivaptan, 807 Availability, drugs, see Drugs, availability Defined America, 1287 lixivaptan, 807 Awards Bortezomib metoprolol tartrate, 636 American Society of Health-System hematologic neoplasms, 1221 tolvaptan, 807 Pharmacists, 2055 Bosentan Cardiopulmonary resuscitation Buffington, D., e49 scleroderma, 315 protocols, 2337 AZD6140 Botox, see Botulinum toxin A Cardiovascular diseases cardiovascular diseases, Jul | suppl S11 Botulinum toxin A platelet aggregation inhibitors, Jul 1 suppl S1, equivalency, therapeutic, Jul 15 suppl S9 Jul 1 suppl S11 Breast neoplasms prophylaxis, 488 B antineoplastic agents, 2221 Careers diagnosis, 23 pharmacists, 69, 119, 164, 912, 1120, 1314, Baclofen epothilones, May 15 suppl S10 1513, 1694, 1991, 2331 hiccup, 2092 home tests, 299 pharmacists, hospital, 1700, 2055 therapy, 1333 ixabepilone, 2017 pharmacists, institutional, hospital, 2014 Bacterial infections lapatinib, 1703 Carotenoids dalbavancin, 599 paclitaxel, 1333 lutein, 1232 resistance, May | suppl $2, May | suppl $4 therapy, May 15 suppl $4, May 15 suppl S16, zeaxanthin, 1232 BAY 59-7939, see Rivaroxaban 1552 Carriers Bendamustine hydrochloride Bronchial fistula hemoglobin, 1110 leukemia, 793 beriplast, 322 Carvedilol Benzodiazepines concomitant therapy, 2117 insomnia, 927 Caspofungin acetate incompatibilities, 454 Am J Health-Syst Pharm—Vol 65 Dec 15, 2008 2401 @ ANNUAL INDEX Cathartics and laxatives Clinical pharmacy pharmacists, 1500 constipation, 1530 computers, 154, 282 protocols, 723, 1755 Catheters cost-benefit analysis, 1123 Compounding contamination, 226 education, pharmaceutical, 194 calcium salts, 73 Cefazolin sodium emergency rooms, 395 indocyanine green, 506 toxicity, 823 services, 229, 566, 690, 844, 906, 1120, 1161, robotics, 14 Cefepime 1254, 1458, 1643, 1655, 1795, 2011 sodium phosphate dibasic, 73 resistance, 1154 telepharmacy, 1310 sterile products, 104, 1173, 1266, 2210, 2212 Cefotaxime Clinical studies Comprehension concomitant therapy, 1430 angiotensin-converting-enzyme inhibitors, patients, 974 Ceftazidime 935 Computers resistance, 1154 antineoplastic agents, 795 documentation, 154 Ceftobiprole medocaril antivirals, 2184 errors, medication, 2265 incompatibilities, 1545 drugs, investigational, 969 formulary system, 510 Ceftriaxone ethics, 1851 hospital pharmacy, 1410, 2244 resistance, 1154 methodology, 2159, 2205 Intranet, 639 Celiac disease pharmacists, 1010 journals, 2155 epidemiology, 1601 reimbursement, Jan 15 suppl S11 medication orders, 570, 1755 Central nervous system stimulants Clonazepam patient care, 2086 methamphetamine, 1109 concomitant therapy, 2122 patient information, 282, 2188 Cephalosporins Clopidogrel programs, 969 cefazolin sodium, 823 acute coronary syndrome, Aug | suppl S22 students, 2091 ceftobiprole medocaril, 1545 cardiovascular diseases, Jul 1 suppl Si, Jul 1 technology, 1012 resistance, 1154 suppl S11 Concentration Cerebellar ataxia therapy, 1019, 1134 acetylcysteine, 558 capecitabine, 2032 Clostridium difficile drugs, 49 Certification resistance, 705 iobenguane sulfate, 142 pharmacists, 166 Clostridium infections mercaptopurine, 441 technicians, 1798 therapy, 705 metoprolol tartrate, 636 Cetuximab Clozapine palonosetron hydrochloride, 1735 colorectal neoplasms, Jun 1 suppl S3, Jun 1 toxicity, 1825 risedronate sodium, 2133 suppl S15 Cocaine Condylomata acuminata Charity abuse, 611 fluorouracil, combination, lidocaine drugs, Jan 15 suppl S11 Codes hydrochloride, 1830 Chlorpromazine bar, 644, 655, 1661 Conivaptan hiccup, 2092 Coenzymes heart failure, 807 Chromatography, liquid sapropterin dihydrochloride, 100 Constipation acetylcysteine, 558 Colonic neoplasms bupropion, 1530 iobenguane sulfate, 142 home tests, 299 methylnaltrexone bromide, 996 ranitidine hydrochloride, 325 Color Contamination Cinacalcet iobenguane sulfate, 142 catheters, 226 calciphylaxis, 1419 metoprolol tartrate, 636 impurities, 325 Cinryze, see Cl inhibitor Colorectal neoplasms microbiological, 280, 636 Ciprofloxacin monoclonal antibodies, Jun 1 suppl S3 particles, 1443 toxicity, 547 therapy, Jun | suppl S8, Jun 1 supp! $15 Contraindications Classification Combined therapy nebivolol hydrochloride, 190 biologicals, Jul 15 supp! S16 antidiabetic agents, 521 Control drugs, 10 antineoplastic agents, Jun | suppl $8, Jun 1 costs, 1368 lovastatin, 101 suppl S15 cross infection, 2080 Classified advertising, see ASHP’s aspirin and clopidogrel, 1134 Control, quality CareerPharm capecitabine and ixabepilone, 2017 air, 1443 Clearance, see Excretion clopidogrel and aspirin, 1134 filters, 2210, 2212 Clevidipine butyrate ixabepilone and capecitabine, 2017 glycerin, 1173 hypertension, 1686 platelet aggregation inhibitors, Jul 1 suppl S1, heparin, 280 Cleviprex, see Clevidipine butyrate Jul 1 suppl $5 indocyanine green, 506 Climate Commentaries, 73, 166, 254, 340, 661, 866, 974, injections, 49, 1648 disease outbreaks, 1112 1076, 1566, 1761, 1846, 2150 insulin, 953 Clinical Consultation, 29, 13322, , 21 219, 315, 414, Common cold nitroglycerin, 1556 540, 611, 818, 935, 1039, 1232, >t 14 19, 1616, phenylephrine, 193 sterile products, 104, 1266 1825, 2027, 2221 Communicable diseases validation, 2276 Clinical pharmacists epidemiology, 2190 Coronary artery bypass ambulatory care, 229, 844 publications, e72 aspirin, 1134 attitudes, 154 therapy, 1595 clopidogrel, 1134 computers, 282 Communication Correction Notices, 101, 286, 380, 695, 795, consultation, 690 errors, medication, 175 998, 1109, 1204, 1399, 1491, 1592, 1597, 1992, cost-benefit analysis, 1123 Food and Drug Administration, 1791 219252522 emergency rooms, 395 pharmacists, hospital, 1631 ASHP Guidelines on Medication Cost interventions, 1161, 1254, 1795 students, 293 Management Strategies for Hospitals reimbursement, 906 Compliance and Health Systems (Jul 15, 2008, ASHP role, 702, 1458, 1643, 1655, 2011, May 1 suppl hospitals, 1590 Report), 1491 $2, May | suppl $4 patients, 297, 661, 1076, 1242, May 15 suppl ASHP Practitioner Recognition Program (Apr services, 145, 566 S16 15, 2008, ASHP 2008 Summer Meeting and telepharmacy, 1310 Exhibition), 1109 2402 Am J Health-Syst Pharm—Vol 65 Dec 15, 2008 ANNUAL INDEX EH Assessing your aptitude for pharmacy Cryptococcosis disease management, 1990 leadership (Sep 15, 2008, Management fluconazole, 619 insulin, 1076, 1347 Consultation), 2322 Current Literature, 1286 insulin glargine, 508 Bias: considerations for research practice (Nov Curriculum pharmaceutical services, 145, 1841 15, 2008, Research Fundamentals), 2192 education, pharmaceutical, 1598, 2045 pioglitazone, 1846 Current and future treatment modalities for Cyclophosphamide protocols, 488 Clostridium difficile-associated disease (Apr concomitant therapy, 1333 rosiglitazone, 1846 15, 2008, Therapy Update), 998 scleroderma, 315 sitagliptin, 521 New drug to restore bowel function approved toxicity, 1552 Diabetic foot under new FDA rules (Jul 1, 2008, News), Cystic fibrosis vancomycin, 1740 1399 dietary supplements, 562 Diagnosis Paclitaxel-induced sickle cell crisis (Jul 15, Cytotoxic agents, see Antineoplastic agents antiphospholipid syndrome, 964 2008, Case Report), 1491 breast neoplasms, 23, 2221 Pharmacist interventions in an inpatient clostridium infections, 705 D geriatric psychiatry unit (Oct 1, 2008, insomnia, 927 Letters), 1992 methodology, 702 Questionable conclusions about epoetin alfa Dacarbazine osteoporosis, 343 (Sep 1, 2007, Letter), 286 melanoma, Dec 15 suppl S3, Dec 15 suppl $9 respiratory syncytial virus infections, Dec 1 Recruiting a manager for financial activities Dalbavancin suppl S7 in pharmacy (Nov 1, 2008, Management bacterial infections, 599 tuberculosis, 2027 Consultation), 2322 Darbepoetin alfa Diagnostic agents Resurgence of colistin use (Dec 1, 2007, reimbursement, 385 indocyanine green, 506 Clinical Consultation), 101 use, 1711 Dialysis Sharing experiences with information Data collection hemo-, 941, 1218, 1248 technology (Jun 1, 2008, Informatics administrators, 1700 pharmaceutical services, 2011 Interchange), 1204 antiretroviral agents, 1796 Diazepam Snowstorm triggers emergency plan for home clinical pharmacists, 154 therapy, 2122 drug delivery (Apr 1, 2008, News), 695 education, pharmaceutical, 1750 Dietary supplements Treatment of poisoning caused by hospital pharmacy, 827, 2045, 2244 cystic fibrosis, 562 B-adrenergic and calcium-channel hospitals, 2036 lutein, 1232 blockers (Oct 1, 2006, Clinical Review), industry, pharmaceutical, 1071 medical histories, 60 1592 methodology, 2276 zeaxanthin, 1232 Two nomograms for determining extended- patients, 1062, 1347, 1498, 2137 Difluprednate dosing intervals for gentamicin in neonates pediatrics, 562 pain, 1394 (Apr 1, 2008, Clinical Report), 795 pharmacists, 631, 1500, 1744 Diluents Update on pharmaceutical reimbursement physicians, 2008 dextrose, 636, 1261, 1735, 2200 and implications for health-system publications, e72 injections, 49, 1648 pharmacists (Jan 15, 2008, Supplement), statistics, 2358 sodium chloride, 636, 1261 286 students, 158, 1358 Disaster planning Visual compatibility of caspofungin acetate Databases pharmaceutical services, 596 with commonly used drugs during drugs, adverse reactions, 1205 Disasters simulated Y-site delivery (Mar 1, 2008, Death hospitals, 1689 Note), 1597 errors, medication, 2367 pharmaceutical services, 902, 2006 Work hard, work smart—the quest for Decitabine Discrimination excellence drives best practice (Jan 15, melanoma, Dec 15 suppl S3 health care, 728 2008, News), 380 Department of Health and Human Services Disease management Cost—benefit, see Economics; cost—benefit databases, 1205 diabetes mellitus, 1990 analysis Department of Veterans Affairs Disease outbreaks Cost-effectiveness, see Economics; cost-benefit education, pharmaceutical, 1797 climate, 1112 analysis pharmaceutical services, 631, 1310, 1458, 1744 epidemiology, 2190 Costs Depression influenza, 1792 antifungals, 2237 antidepressants, 700, 1108 respiratory syncytial virus infections, Dec | bortezomib, 1221 bupropion, 1530 suppl S13 drugs, 1368, Jan 15 suppl S4 varenicline, 1624 Disinfectants epoetin alfa, 540 Desmopressin poisoning, 2203 nebivolol, 1125 therapy, 941 Dispensing prescription drugs, 234, 552, 1062 Det Norske Veritas Healthcare errors, medication, 429 teriparatide, 532 accreditation, 2084 nomenclature, 1801 tests, laboratory, 1493 Developing countries pharmacists, 10 Coxsackievirus infections pharmacists, 194 Docetaxel therapy, 132 Devices toxicity, 1552 Cranberry, see Vaccinium macrocarpon drug administration, 1347 Documentation Creatinine insulin, 698 computers, 154 blood levels, 138 medical, 280, 1076 drug administration, 655 Critical illness Dexamethasone drugs, adverse reactions, 1177 epoetin alfa, 540 concomitant therapy, 1048, 2229 medical histories, 857 injections, 1648 Dextrose Docusate sodium Crohn disease diluents, 636, 1261, 1735, 2200 constipation, 1530 ciprofloxacin, 547 vehicles, 1545 Dopamine antagonists Cross infection Diabetes mellitus therapy, 414 hospitals, 2080 angiotensin-converting-enzyme inhibitors, Doripenem 935 incompatibilities, 1261 Am J Health-Syst Pharm—Vol 65 Dec 15, 2008 2403 BM ANNUAL INDEX Dosage Drug administration routes lung diseases, 1533 aliskiren, 1323 epidural, 458 pharmaceutical services, 490, 844, 1655 anticoagulants, 334, Aug 1 suppl $22 intranasal, 65 Drug withdrawal antidepressants, 1029 intrathecal, 701 alcohols, ethyl, 1039, 2205 antiinfective agents, 203 intraurethral, 1830 Drugs antipsychotic agents, 42 vaginal, 254 approvals, 190, 1363, 1595 antiretroviral agents, 55 Drug comparisons generic, 234, 552 bortezomib, 1221 alteplase and urokinase, 1435 latentiated, 1019 capecitabine, 2032 antifungals, 2237 orphan, 1205 droperidol, 201 clopidogrel and prasugrel, 1019 selection, May | suppl $2, May | suppl S4, eculizumab, 1609 filgrastim and lenograstim, 1552 927, Aug 1 suppl S5, Aug 1 suppl $22, 1599 errors, medication, 429, 2036 lenograstim and filgrastim, 1552 unapproved, 1594 fenofibrate, 138 paliperidone and risperidone, 401 unlabeled use, 908, 1815, Jan 15 suppl S4 filgrastim, 1552 prasugrel and clopidogrel, 1019 Drugs, adverse reactions fluconazole, 619 risperidone and paliperidone, 401 see also Toxicity gentamicin, 624 urokinase and alteplase, 1435 databases, 1205 iron sucrose, 150 Drug histories, see Patient information; drug hospitals, 2036 ixabepilone, 2017 histories reports, 1177 lapatinib, 1703 Drug distribution rivastigmine, 1051 methotrexate, 2117 alcohols, ethyl, 2200 varenicline, 1239 nebivolol, 1125 disaster planning, 596 Drugs, availability nebivolol hydrochloride, 190 disasters, 902 aliskiren, 1323 nitroglycerin, 1556 Drug information Drugs, body distribution omeprazole, 422 Food and Drug Administration, 803 dalbavancin, 599 overdose, 508, 686 industry, pharmaceutical, 1071 gentamicin, 624 paliperidone, 403, 2122 Intranet, 639 Drugs, investigational phenylephrine, 193 Drug information centers protocols, 969 platelet aggregation inhibitors, 1017, Jul Food and Drug Administration, 803 sterile products, 1266 suppl $11, Aug 1 suppl $22 industry, pharmaceutical, 1071 Drugs, over the counter prazosin, 716 Drug interactions lovastatin, 101 sitagliptin, 521 aliskiren, 1323 Durezol, see Difluprednate topiramate, 1430 amiodarone and haloperidol, 2232 Dyspepsia vancomycin, 1740 amiodarone and warfarin, 947 metoclopramide, 1057 warfarin, 947, 964, 1144, Aug 1 suppl S13 anticonvulsants, 1720 Dysport, see Botulinum toxin A Dosage forms antidepressants, 700 drugs, 2347 antineoplastic agents, May 15 supp] $10 metoclopramide, 1057 antiretroviral agents, 55 opiates, 381] aprepitant and ifosfamide, 2229 Dosage schedules benzodiazepines and olanzapine, 1180 Economics dalbavancin, 599 carbamazepine, 1039 American Society of Health-System fertility agents, 1148 dalbavancin, 599 Pharmacists, e41 hematopoietic agents, 1711 eculizumab, 1609 antiinfective agents, 2095 patient-controlled analgesia, 1184 enteral nutrition, 2347 cost-benefit analysis, 229, 540, 1458, 1464, vancomycin, 1248 food and lapatinib, 1703 1841, Jul 15 suppl S2 Doxorubicin haloperidol and amiodarone, 2232 health care, 1399 toxicity, 1552 ifosfamide and aprepitant, 2229 hospital pharmacy, 340, 2014 Dreams immunomodulating agents and natalizumab, journals, 1511 prazosin, 716 18 prescription drugs, 234, 2137 Droperidol indinavir, omeprazole and ritonavir, 422 respiratory syncytial virus infections, Dec 1 toxicity, 201 lapatinib, 1703 suppl S3 Drug abuse natalizumab and immunomodulating agents, venous thrombosis, 866 alcohols, ethyl, 611 18 Eculizumab amphetamines, 611 olanzapine and benzodiazepines, 1180 hemoglobinuria, 1609 cocaine, 611 omeprazole, indinavir and ritonavir, 422 Editorials, 207, 297, 401, 1017, 1123, 1321, 1511, methamphetamine, 1109 paliperidone, 403 1607, 1803 opiates, 381 pharmaceutical services, 1744 A tool kit for practice-based research, 1607 quetiapine, 611 prasugrel, 1019 Aligning payment with quality, 1512 Drug administration ritonavir, indinavir and omeprazole, 422 Aliskiren: will a novel mechanism improve aliskiren, 1323 sitagliptin, 521 clinical outcomes?, 1321 anesthetics, 655 Vaccinium macrocarpon and warfarin sodium, Bridging the gap between evide..ce and bar codes, 644 2113 practice in osteoporosis, 297 bortezomib, 1221 warfarin and amiodarone, 947 For better or for worse: the future of difluprednate, 1394 warfarin sodium and Vaccinium macrocarpon, antiplatelet therapy, 1017 eculizumab, 1609 2113 Hospitalist-pharmacist collaboration: only enteral nutrition, 2347 Drug product selection, see Substitution, natural, 207 errors, medication, 429, 1494, 1661 therapeutic Open-access publishing: why not?, 1511 hospital pharmacy, 1793 Drug use Paliperidone: an improvement over hospitals, 254 antiinfective agents, 1154, 1396, 2095, May 1 risperidone?, 401 injections, 1648, 1834 suppl $2, May | suppl S4 Realizing the pharmacoeconomic benefit of insulin, 698, 1076, 1347 asthma, 1533 clinical pharmacy, 1123 lapatinib, 1703 evaluation, 1458 Why ASHP publishes Best Practices, 1803 morphine sulfate, 458 hematopoietic agents, 1711 paliperidone, 403 2404 Am J Health-Syst Pharm—Vol 65 Dec 15, 2008 ANNUAL INDEX Education Epoetin alfa Fertilization in vitro health professions, 861 anemia, 540 fertility agents, 1148 personnel, 281 use, 1711 Fesoterodine fumarate Education, pharmaceutical Epoetin beta overactive bladder, 2184 anticoagulants, 1508 combination, polyethylene glycol Fibrin glue, see Beriplast clinical pharmacy, 566 monomethy] ether, 10 Filgrastim compounding, 104 Epothilone B neutropenia, 1552 distance learning, 912 breast neoplasms, May 15 suppl S10 Filters educators, 1694 Epothilones membrane, 1173, 2210, 2212 hospital pharmacy, 1750, 2045 breast neoplasms, May 15 suppl S10 Filtration internships, 283 Equipment sterilization, 1173 Japan, 201 control, quality, 1443 Flavors methodology, 1598 Equivalency, therapeutic solutions, 558 pharmacists, 194 biologicals, Jul 15 suppl S2, Jul 15 suppl $9, Jul Fluconazole pharmacists, hospital, 649, 1266 15 suppl S16 neutropenia, 2237 residencies, 117, 166, 293, 999, 1358, 1797, Errors toxicity, 619 2091 hospitals, 1686 Flucytosine students, 158, 1502 research, 2159, 2276 concomitant therapy, 619 technicians, 1798 Errors, medication Fluorouracil Educators anticoagulants, 334 colorectal neoplasms, Jun | suppl S15 pharmacists, 912, 1694, 1991 antiretroviral agents, 55 combination, lidocaine hydrochloride, 1830 pharmacy, 158 computers, 2265 concomitant therapy, 1333 Electrocardiography drug administration, 1661, 1793 Folic acid amiodarone, 2232 emergency rooms, 330 therapy, 1333 haloperidol, 2232 hospitals, 175, 595, 1254, 2036, 2047 Follicle stimulating hormone, see Electrolytes injections, 14, 49, 1494, 1648, 1834, 2367 Urofollitropin potassium chloride, 1735, 2122 insulin, 698 Fomepizole Elimination, see Metabolism methotrexate, 2117 antidotes, 2200 Emergencies nomenclature, 386 Fondaparinux heart arrest, 2337 patient-controlled analgesia, 429 acute coronary syndrome, Aug | suppl $22 pediatrics, 649 prevention, 1451, 1566, 1631 thrombocytopenia, 334 Employment reimbursement, Jan 15 suppl S11 Food pharmacists, 2100 roentgenographic agents, 1400 interactions, 1703 Emulsions Erythema multiforme Food and Drug Administration (U.S.) parenteral nutrition, 1117 phenytoin, 1048 approvals, 1595 Enalapril Escitalopram biologicals, Jul 15 suppl $16 concomitant therapy, 2122 concomitant therapy, 2122 clinical studies, 795, 1010 toxicity, 420 Ethics communication, 1791 Endoscopy capital punishment, 2204 drug information centers, 803 beriplast, 322 clinical studies, 1851 labeling, 1533 Energy Ethnic groups phenylephrine, 193 pharmacists, 1404 African Americans, 2137 regulations, 10, 101, 280, 908, 1363, 1594, Enoxaparin Caucasians, 2137 1988 acute coronary syndrome, Aug | suppl $22 patients, 728 Formularies therapy, 37 Ethylene glycol hospitals, 1363 venous thromboembolism, Aug | suppl $5 poisoning, 2200 Formulary system Entereg, see Alvimopan Etoposide hospital pharmacy, 1272, 2384 Enterocolitis concomitant therapy, 2229 hospitals, 510 therapy, 705 European Union Formulations Environmental Protection Agency biologicals, Jul 15 suppl S2 opiates, 381 inspections, 498 Exanthema Fractures Enzyme inhibitors varenicline, 1239 teriparatide, 532 C1 inhibitor, 2080 Excipients Frontline Pharmacist, 203, 395, 510, 1218, 1603, methylene blue, 2229 glycerin, 1173 2011, 2095 Eovist, see Gadoxetate disodium sorbitol, 2347 Clinical pharmacist’s daily role in the Epidemiology Ezetimibe emergency department of a community celiac disease, 1601 combination, simvastatin, 594 hospital, 395 communicable diseases, 2190 Defining an antimicrobial monitoring service, cross infection, 2080 2095 infections, 1496 Development and maintenance of an online influenza, 1112 formulary for a large health system, 510 osteoporosis, 1601 Factor Vila Development of a pediatric pocket-sized papillomavirus infections, 2105 hemorrhage, 1616 guide for antimicrobial therapy, 203 respiratory syncytial virus infections, Dec | Factor VIII, see Antihemophilic factor Implementation of clinical pharmacy services suppl S3, Dec 1 suppl S13 Famotidine in a dialysis unit, 2011 Epilepsy incompatibilities, 1735 Implementation of insulin infusion guidelines anticonvulsants, 1720 Fenofibrate in a neonatal intensive care unit, 1603 Epinephrine toxicity, 138 Role of a pharmacist on the dialysis unit, 1218 spectrometry, 49 Fertility agents Epirubicin buserelin acetate, 1148 concomitant therapy, 1333 gonadotropin chorionic, 1148 urofollitropin, 1148 Am J Health-Syst Pharm—Vol 65 Dec 15, 2008 2405 BM ANNUAL INDEX G H beriplast, 322 factor Vila, 1616 thrombin, 380 Gabapentin Half life Heparin therapy, 1039 lapatinib, 1703 acute coronary syndrome, Aug 1 suppl $22 Gadoxetate disodium Half-life control, quality, 280 overview, 1490 dalbavancin, 599 thromboembolism, 1643 Gases gentamicin, 624 nitric oxide, 29 monoclonal antibodies, Jun 1 suppl $3 toxicity, 334, 1144, Aug 1 suppl $13 Gastric emptying Haloperidol . venous thromboembolism, Aug 1 suppl $5 metoclopramide, 1057 interactions, 2232 Heparin sodium Gastrointestinal drugs toxicity, 1029 incompatibilities, 1735 alvimopan, 1204 Health-benefit programs Heparins famotidine, 1735 Medicaid, 890, 1720, 2084 low molecular weight, 866 metoclopramide, 1057 Medicare, Jan 15 suppl S4, Jan 15 suppl S11, Hepatic encephalopathy rifaximin, 818 omeprazole, 422 234, 595, 800, 890, 1062, 1590, 1655, 1686, Hepatitis B pantoprazole, 37 2084, 2152 ranitidine hydrochloride, 325 prescription drugs, 1004 antivirals, 2184 Hiccup Gels third party, 1399, 1512 fluorouracil, combination, lidocaine Health care therapy, 414, 2092 hydrochloride, 1830 computers, 2086 History hospital pharmacy, 1793 Genetics discrimination, 728 antidepressants, 1108 economics, 1399 HIV infections breast neoplasms, 2221 geriatrics, 999 antiretroviral agents, 55, 686 pain, 1212,1588 patient education, 1311 indinavir, 422 omeprazole, 422 tests, 23, Aug 1 suppl $13 patient information, 2188 prophylaxis, 1796 tests, laboratory, 793, 1399, 1493 quality assurance, 692, 1566 Gentamicin team, 2152 ritonavir, 422 dosage, 624 Health Care Financing Administration, see HMOs, see Managed care systems spectrometry, 49 Centers for Medicare and Medicaid Services Home, health care, see Health care; home Geriatrics Health maintenance organizations, see Home tests arsenic trioxide, 941 Managed care systems International Normalized Ratio, 800 beriplast, 322 Health professions women, 299 economics, 2137 education, 861 Hormones fluconazole, 619 HIV infections, 1796 teriparatide, 532 health care, 999 immunization, 1308 Hospital pharmacy, see Pharmacy, lutein, 1232 role, 2047 institutional, hospital medical histories, 60 Heart arrest Hospitals nebivolol, 1125 protocols, 2337 accreditation, 1590, 2084 pharmaceutical services, 1795 Heart defects antiinfective agents, 203, 2095, May 1 suppl rivastigmine, 1051 antiinfective agents, 2008 S2, May 1 suppl S4 tolterodine, 1054 Heart failure antiretroviral agents, 55 vaccines, 996 vasopressin antagonists, 807 bar codes, 644 varenicline, 1239 Heart surgery compounding, 14 warfarin sodium, 2113 antiinfective agents, 2008 costs, 1368 zeaxanthin, 1232 Helicobacter infections disasters, 1689 Globulin immune metoclopramide, 1057 discharge, 1451, 1631 clostridium infections, 705 Hematopoietic agents drug administration, 254, 655 myocarditis, 132 anemia, 1218, 1458 drug information, 639 therapy, 1815 darbepoetin alfa, 385, 1711 drugs, adverse reactions, 1177 Glomerular filtration rate epoetin alfa, 540, 1711 drugs, investigational, 969 fenofibrate, 138 epoetin beta, combination, polyethylene emergency rooms, 60, 330, 395, 2380 Glycerin glycol monomethyl ether, 10 errors, 1686 sterilization, 1173 equivalency, therapeutic, Jul 15 suppl S9 errors, medication, 175, 1254, 1494, 1661, Gonadotropin chorionic filgrastim, 1552 2036, 2265, 2367 toxicity, 1148 lenograstim, 1552 formularies, 1363 Gram negative bacteria reimbursement, Jan 15 suppl $11 formulary system, 510 resistance, 1154 Hemoglobin hematopoietic agents, 1711 Group purchasing, see Purchasing Guidelines carriers, 1110 HIV infections, 1796 Guatemala Hemoglobinuria insulin, 1347 pharmaceutical services, 117 eculizumab, 1609 intensive care units, 1464, 1603, 1834, 2090 Guidelines Hemophilia A length of stay, 42, 1740, Aug 1 suppl $5 American Society of Health-System antihemophilic factor, 592 lymphoma, 1471 Pharmacists, 172, 260, 462, 728, 1272, 1368, Hemorrhage morphine sulfate, 458 1803, 2380, 2384 aspirin, 1134 patient care, 207, 260 cross infection, 2080 clopidogrel, 1134 patient-controlled analgesia, 1184 International Pharmaceutical Federation, factor VIla, 1616 protocols, 861, 1180 1996 platelet aggregation inhibitors, 1017 quality assurance, 827, 897, 2047 Guidelines, treatment, see Protocols warfarin, Aug 1 suppl $13 regulations, 890 Hemorrhoids reimbursement, 595 bupropion, 1530 safety, 281 Hemostatics venous thromboembolism, 1755 antihemophilic factor, 592 waste disposal, 498 2406 Am J Health-Syst Pharm—Vol 65 Dec 15, 2008 ANNUAL INDEX Hours myocarditis, 132 morphine sulfate, 458 after-hours service, 1727 tacrolimus, 226 olanzapine, 1180 pharmacists, hospital, 2144 transplantation, 1242 palonosetron hydrochloride, 1735 Human chorionic gonadotropin, see Incompatibilities phosphates, 1761 Gonadotropin chorionic aripiprazole and lorazepam, 2007 propofol, 2090 Hydrochlorothiazide calcium salts and sodium phosphate dibasic, sodium phosphate dibasic, 73 concomitant therapy, 1054 73 spectrometry, 49 Hydrocortisone caspofungin acetate, 454 Insomnia hemorrhoids, 1530 ceftobiprole medocaril, 1545 anxiolytics, sedatives and hypnotics, 1004 Hydrogen ion concentration doripenem, 1261 therapy, 927 aripiprazole, 2007 drugs, 1648, 2210, 2212, 2347 Inspections injections, 1648 injections, 1834 Environmental Protection Agency, 498 lorazepam, 2007 lorazepam and aripiprazole, 2007 hospitals, 890 metoprolol tartrate, 636 palonosetron hydrochloride, 1735 Insulin ranitidine hydrochloride, 325 phosphates, 1761 administration, 698, 1347 Hydromorphone risedronate sodium and suspending agents, diabetes mellitus, 1076 spectrometry, 49 2133 hyperglycemia, 1603 Hydroxyurea sodium phosphate dibasic and calcium salts, spectrometry, 49 anemia, 592 fe: Insulin glargine Hyperalimentation, see Nutrition; parenteral suspending agents and risedronate sodium, concomitant therapy, 2122 Hypercholesterolemia 2133 overdose, 508 ezetimibe, combination, simvastatin, 594 Indinavir Insulin human Hyperglycemia interactions, 422 combination, insulin human isophane, 953 insulin, 1603 Indocyanine green stability, 953 Hypertension compounding, 506 Insulin human isophane aliskiren, 1321, 1323 Industry, pharmaceutical combination, insulin human, 953 clevidipine butyrate, 1686 drug information, 1071 stability, 953 methamphetamine, 1109 marketing, 908 Insulin lispro nebivolol, 1125 product development, 1595 concomitant therapy, 2122 nebivolol hydrochloride, 190 Infections Insulins tests, 209 epidemiology, 1496 insulin, 49, 698, 1076, 1347, 1603 Hypertriglyceridemia Influenza insulin glargine, 508 fenofibrate, 138 epidemiology, 1112 insulin human, 953 Hypokalemia immunization, 1792 insulin human, combination, insulin human fluconazole, 619 Influenza vaccines isophane, 953 Hyponatremia immunization, 1308, 1792 insulin human isophane, 953 tolterodine, 1054 Informatics Interchange, 1012, 1410, 1801, Interferon alfa Hypoprothrombinemias 2216 melanoma, Dec 15 suppl S3 cefazolin sodium, 823 A new term for transcribing, 1801 Interleukin-2 Hypotensive agents Bar-code medication administration: a melanoma, Dec 15 suppl S3 aliskiren, 1321, 1323 systems perspective, 2216 International Normalized Ratio bosentan, 315 Pharmacy informatics: aligning for success, cefazolin sodium, 823 hypertension, 209 1410 warfarin, 800, 947, 964 medical histories, 60 Sharing experiences with information warfarin sodium, 2113 nebivolol, 1125 technology, 1012 International Pharmaceutical Federation nebivolol hydrochloride, 190 Information policies and procedures, 1996 prazosin, 716 technology, 1012, 1410 Internet Infusion devices, see Devices; infusion pumps drug information, 803 Inhalers formulary system, 510 see also Aerosols journals, 2155 patient information, 65 patient information, 2188 Iatrogenic diseases, see Drugs, adverse Injections Interventions reactions alcohols, ethyl, 2200 clinical pharmacists, 1161, 1254, 1795, 2011 Ibuprofen aripiprazole, 2007 pharmacists, 857, 1841, 1854 therapy, 37 benzodiazepines, 1180 pharmacists, hospital, 330 Identification calcium salts, 73 Interviews roentgenographic agents, 1400 capital punishment, 2204 pharmacists, 2100 Ifosfamide caspofungin acetate, 454 Investigational drugs, see Drugs, interactions, 2229 ceftobiprole medocaril, 1545 investigational Immunization clevidipine butyrate, 1686 lobenguane sulfate influenza, 1308, 1792 compounding, 14 stability, 142 papillomavirus infections, 2105, 2150 dalbavancin, 599 Ipilimumab pharmacists, 1500 doripenem, 1261 melanoma, Dec 15 suppl S9 Immunogenicity drugs, 1648 Irbesartan biologicals, Jul 15 suppl S2 errors, medication, 1494, 2367 toxicity, 420 botulinum toxin A, Jul 15 suppl S9 gentamicin, 624 Irinotecan Immunoglobulin, see Globulin immune incompatibilities, 1834 colorectal neoplasms, Jun 1 suppl S15 Immunomodulating agents insulin, 1347, 1603 Iron preparations interactions, 18 iobenguane sulfate, 142 anemia, 1458 Immunosuppressive agents iron sucrose, 150 iron sucrose, 150 cyclophosphamide, 315 lorazepam, 2007 Iron sucrose metoprolol tartrate, 636 anemia, 150 Am J Health-Syst Pharm—Vol 65 Dec 15, 2008 2407 BM ANNUAL INDEX Isoniazid Disaster relief efforts of pharmacy students Lixivaptan tuberculosis, 2027 during California wildfires, 2006 heart failure, 807 Itraconazole Energy provided by propofol infusion, 2090 Location neutropenia, 2237 Extended-release epidural morphine and hospitals, 1796 Ixabepilone postoperative nausea or vomiting, 200 Lomeguatrib breast neoplasms, 2017, May 15 suppl S10 Hiccups and dopamine, 2092 melanoma, Dec 15 suppl S3 HIV postexposure prophylaxis availability in Long QT syndrome U.S. rural hospitals, 1796 antidepressants, 1029 Important lessons in opioid selection, 1599 antipsychotic agents, 1029 Indocyanine green availability from ciprofloxacin, 547 Japan compounding pharmacies, 506 Lorazepam education, pharmaceutical, 201 Industry promotion of unlabeled uses, 908 incompatibilities, 2007 hospital pharmacy, 2055 Ingestion of hand sanitizer by a hospitalized spectrometry, 49 Job satisfaction patient with a history of alcohol abuse, Lovastatin pharmacists, 69, 119, 164, 514, 1404 2203 classification, 101 Job sharing Instructing pharmacy students with Lung diseases pharmacists, 69 interactive clinical cases, 1598 tacrolimus, 226 Joint Commission Need for residency programs in health-system therapy, 1533 hospitals, 897 pharmacy administration in the VA health Lutein protocols, 1396 care system, 1797 macular degeneration, 1232 Journals Online tool for pharmacy students seeking Lymphoma Internet, 2155 residency positions, 2091 bortezomib, 1221 pharmacy, 1511, 1539 Patient preferences for ongoing warfarin therapy, 1471 management after receiving care by an K anticoagulation management service, 1498 M Pharmacist interventions in an inpatient geriatric psychiatry unit, 1795 Kidney diseases Pharmacists and executive, 2204 Macrolides fenofibrate, 138 Pharmacists as investigators in FDA-regulated telithromycin, 37 therapy, 1419 drug trials, 1010 Macular degeneration Kidney failure Reimbursement for medication therapy lutein, 1232 cefazolin sodium, 823 management services, 906 ranibizumab, 1805 epoetin beta, combination, polyethylene Short-term physical compatibility of zeaxanthin, 1232 glycol monomethyl ether, 10 intramuscular aripiprazole with Magnetic resonance imaging fenofibrate, 138 intramuscular lorazepam, 2007 gadoxetate disodium, 1490 vancomycin, 1248 Sufficiency of data for resuming use of low- Managed care systems, see Health maintenance warfarinA,ug 1 suppl $13 dose droperidol, 201 organizations Survey of congenital heart surgeons’ Management, see Administration preferences for antimicrobial prophylaxis Management Consultation, 20, 1700, 2014 for pediatric cardiac surgery patients, 2008 Assessing your aptitude for pharmacy Labeling Unintentional overdose of insulin glargine, leadership, 1700 drugs, 890, 1533 508 Development of a work-force retention Lamotrigine Vaccination adherence and perceptions program, 20 concomitant therapy, 2122 among infectious diseases pharmacists, Recruiting a manager for financial activities in Lapatinib 1500 pharmacy, 2014 breast neoplasms, 1703 Validity of conclusions about quetiapine, 114 Manpower Laws Washout period for immune-modifying drugs pharmacists, 20, 166, 1006, 2144 Medicare, 1655 before natalizumab therapy, 18 Marketing Orphan Drug Act, 1205 Leucovorin industry, pharmaceutical, 908 pharmaceutical services, 1006 colorectal neoplasms, Jun 1 suppl $15 nomenclature, 175 waste disposal, 498 Leukemia paliperidone, 401 Lenograstim arsenic trioxide, 941 Mast-cell stabilizers neutropenia, 1552 bendamustine hydrochloride, 793 use, 1533 Lepirudin Leukotriene antagonists Mechanism of action thrombocytopenia, 334 use, 1533 aliskiren, 1321, 1323 Letters, 18, 114, 200, 506, 698, 906, 1010, 1117, Levoleucovorin angiotensin-converting-enzyme inhibitors, 1498, 1598, 1795, 2006, 2090, 2200, 2324 therapy, 686 935 Billing and reimbursement for intrathecal Lexiscan, see Regadenoson antidepressants, 1108 opiate therapy, 701 Lidocaine antineoplastic agents, May 15 suppl $10, Dec Caution in prescribing antidepressants for pain, 723 15 suppl S9 patients with cancer, 700 Lidocaine hydrochloride antivirals, 2184 Celiac disease and osteoporosis, 1601 combination, fluorouracil, 1830 anxiolytics, sedatives and hypnotics, 927 Certification of pharmacy technicians, 1798 incompatibilities, 1735 bisphosphonates, 1419 Changes in Japanese pharmacy education and Liposomes bortezomib, 1221 practice, 201 lidocaine, 723 Cl inhibitor, 2080 Conformance with USP chapter 729 for morphine sulfate, 458 chlorpromazine, 2092 parenteral nutritional emulsions, 1117 Lisinopril cinacalcet, 1419 Conversion to insulin devices in the inpatient toxicity, 420 dalbavancin, 599 setting, 698 Literature eculizumab, 1609 Discontinuation of 5% alcohol in 5% dextrose research, 1767 fesoterodine fumarate, 2184 injection: Implications for antidote Liver diseases globulin immune, 132 stocking, 2200 telithromycin, 37 ixabepilone, 2017 lapatinib, 1703 2408 Am J Health-Syst Pharm—Vol 65 Dec 15, 2008